Author(s): Ariza MA, Vimalananda VG, Rosenzweig JL, Ariza MA, Vimalananda VG, Rosenzweig JL
Abstract Share this page
Abstract Diabetes-related care and complications constitute a significant proportion of the United States' (US) health care expenditure. Of these complications, cardiovascular disease (CVD) is a major component. Higher morbidity and mortality rates translate to higher costs of care in patients with diabetes compared to those who do not have the disease. Minorities bear a disproportionate burden of diabetes and CVD. We review this disparity and examine potential etiologies for it in Hispanics and African-Americans, the two largest minority groups in the US. We examine strategies in these populations that may improve outcomes in diabetes and CVD, potentially decreasing health care costs.
This article was published in Rev Endocr Metab Disord
and referenced in Cardiovascular Pharmacology: Open Access